Sonnet BioTherapeutics HoldingsSONN 
$1.59-1.24%24h
-1.24%24h
Global rank32620
Market cap$1.65M
Change 7d-20.50%
YTD Performance-8.62%
SP500 benchmarkUnderperform
P/E-0.09
P/S11.17
Revenue$147.81K
Earnings-$18.83M
Dividend yield-
Main Sector
Healthcare
EPS for Sonnet BioTherapeutics Holdings (SONN)
Sonnet BioTherapeutics Holdings has an EPS of $-18.14. In 2022, the company made an earnings per share (EPS) of $-150.52. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for SONN
-
Value:-
EPS history for Sonnet BioTherapeutics Holdings from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$18.14 | -87.95% |
| 2022 | -$150.52 | -51.99% |
| 2021 | -$313.50 | -85.38% |
| 2020 | -$2.14K | - |
View the highest EPS stocks
